Loading, please wait...
This page is best viewed on a desktop or laptop computer.
|
Scroll to the bottom of the page to register! Register for just $200!
Pharmacy residents may register for $150. Pharmacy students may register for $50.
A total of 11.0 contact hours of CPE credit are offered. Pharmacists attending the full conference can earn a maximum total of 10.0 contact hours of CPE credit.
|
The Midwest Medication Safety Symposium (M2S2) is an interdisciplinary meeting created to provide an opportunity for health-care providers to collaborate and learn new medication safety strategies. The conference focuses on improving medication safety practices and patient outcomes through education of pharmacists and interprofessional health care teams. Sponsored by St. Louis College of Pharmacy, the St. Louis Area Medication Safety Collaborative (SLAMS), and the Indianapolis Coalition for Patient Safety (ICPS), this conference invites health professionals from around the Midwest for a variety of presentations, breakout sessions, and networking opportunities.
Check this web page often as updates and specific information regarding sessions will be added regularly. We hope you are able to join us!
|
KEYNOTE SPEAKER: CHRISTINA MICHALEK
|
|
 |
Christina Michalek is a Medication Safety Specialist and serves as the Administrative Coordinator for the Medication Safety Officers Society at the Institute for Safe Medication Practices. She works collaboratively with health-system leaders and clinical staff participating in proactive risk assessments, targeted risk assessments, root cause analyses, and educational seminars and workshops to define and improve medication safety initiatives. Under contract to the Patient Safety Authority, she served a Patient Safety Analyst for the Pennsylvania Patient Safety Reporting System and she is an analytic contractor for the ECRI Institute Patient Safety Organization. Christina has more than 20 years of acute care hospital pharmacy experience involving clinical practice, management, and leadership. She is a residency-trained graduate of the University of the Sciences’ Philadelphia College of Pharmacy and a Fellow of the American Society of Health-System Pharmacists.
|
| Hosting Organizations: | Location Information: | Hotel Information: | ||
   |
St. Louis College of Pharmacy
Academic & Research Building
4588 Parkview Place
St. Louis, MO 63110
Parking Information
Please note that there are DIFFERENT parking instructions for Friday and Saturday. STLCOP Students and Faculty must continue to park as their hang tags allow.
On FRIDAY, please park at the Laclede Garage located at 4929 Forest Park Ave, 63108. When you arrive, you will be given a parking validation ticket so you can exit the garage later.
On SATURDAY, park at the STLCOP garage located at 4531 Children's Place, 63110. You will not need a validation ticket to exit the garage
|
The Parkway Hotel
4550 Forest Park Avenue
St. Louis, MO 63108
Located within walking distance of the college! Discounted rooms are no longer available; however, guests may still reserve rooms at the hotel's regular rate by calling the number below.
Call 314.256.7777 or visit theparkwayhotel.com
|
||
| Sponsored by: | Follow us! | Fun Things to Do in St. Louis: | ||
|
Platinum Sponsors:
Baxter
MedTronic
Portola Pharmaceuticals
St. Louis College of Pharmacy
Gold Sponsors:
DYNALABS
Healthcare Infection Control Solutions
Merck
Relypsa, Inc.
Silver Sponsors:
Novartis Pharmaceuticals Corporation
Primaris
Bronze Sponsors:
Indianapolis Coalition for Patient Safety
Mercy Hospital
|
   |
Balloon Glow in Forest Park
Friday, September 20, 2019
5:00 PM - Join us after the conference!
|
||
St. Louis College of Pharmacy is committed to independence and transparency in all educational programming. No promotional activities will be permitted in the same room or obligate path to the educational activities. No product advertisements will be permitted in the activity rooms and all marketing materials are subject to prior approval.
|
REGISTER BELOW!
Scroll to the bottom of the page. Registration fee is $200.
|
Date: Sep 20, 2019 07:30 AM - Sep 21, 2019 02:00 PM
Fee
$200.00
CE Hours
11.00
Registration closes on Sep 20, 2019 12:00 AM
Activity Type
- Knowledge and Application
Target Audience(s)
- Pharmacists
Accreditation(s)
|
St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. To learn more about the specific program information, including universal activity numbers (UAN's) and learning objectives, please expand the modules below. Following successful completion of an evaluation, CE credit will be automatically reported to NABP through the CPE Monitor system, using the NABP ePID numbers and date of birth (MMDD) stored in participants' user profiles. Follow this link to learn more about CPE Monitor and the credit reporting process » Participants are responsible for ensuring receipt of credit; no credit can be corrected or awarded if more than 60 days have passed from the date of the event or if the home study is expired.
It is the policy of St. Louis College of Pharmacy at the University of Health Sciences and Pharmacy in St. Louis, to ensure balance, independence, objectivity and scientific rigor in all its educational programs. All faculty participating in this program are expected to disclose to the program audience any real or apparent conflicts of interest related to the content of the presentation.
|
Joint Provider(s)
St. Louis Area Medication Safety Collaborative (SLAMS) & Indianapolis Coalition for Patient Safety (ICPS)
Requirements for CE Credit
To receive CPE credit, pharmacists must complete the following:
- Register and pay with a valid account, including an accurate NABP e-Profile ID and date of birth (month and day).
- Attend all sessions.
- Complete an online evaluation for each session attended on this page (must be logged in to complete). Evaluations are available until October 3rd after which time they will close and credit can no longer be claimed. If you miss the evaluation deadline, an additional fee may be incurred for late CE submission; please refer to our policy on the FAQ page for additional details.
Upon successful completion of an evaluation, a report will be generated using the NABP ePID and date of birth that are connected with your profile. This report will be automatically submitted to CPE Monitor. Please allow up to 48 hours for CPE Monitor to sync with NABP. Participants are responsible for ensuring accurate credit reporting. If a participant believes an error has been made, they should contact our office as soon as possible to resolve the issue. Credit cannot be awarded or corrected—for any reason—after 60 days have passed (beginning Tuesday, November 19, 2019).
A total of 11.0 contact hours of CPE credit are offered. Pharmacists attending the full conference can earn a maximum total of 10.0 contact hours of CPE credit.
Refund Policy
All registration sales are final. No refunds will be issued for this conference.
|
Learn more! Click the + symbol beside each session to expand.
|
REGISTRATION RATES:
Regular Registration: $200
Pharmacy Resident: $150
Pharmacy Student: $50
Refund Policy: All registration sales are final. No refunds will be issued for this conference.
|
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
Registration closes on Sep 20, 2019
at 12:00 AM
Registration closes on Sep 20, 2019
at 12:00 AM
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
This program will highlight ISMP's conceptual model, the Key Elements of the Medication Use System™ as a fundamental strategy to be used during error and near-miss investigations. Through case-bsed discussions we will identify and discuss active and latent failures and provide recommendations for systematic changes to support safer medication use.
Objectives
- Identify examples of latent and active failures that play a contributing role in medication errors.
- Identify key elements of the medication use system that contribute to medication errors.
- Use proven safety tools to investigate system-based causes of medication error and reach actionable conclusions through successful error analysis.
Speaker(s)/Author(s)
|
Christina Michalek, Pharm.D.
Brief Bio : Christina Michalek is a Medication Safety Specialist and serves as the Administrative Coordinator for the Medication Safety Officers Society at the Institute for Safe Medication Practices. She works collaboratively with health-system leaders and clinical staff participating in proactive risk assessments, targeted risk assessments, root cause analyses, and educational seminars and workshops to define and improve medication safety initiatives. Under contract to the Patient Safety Authority, she served a Patient Safety Analyst for the Pennsylvania Patient Safety Reporting System and she is an analytic contractor for the ECRI Institute Patient Safety Organization. Christina has more than 20 years of acute care hospital pharmacy experience involving clinical practice, management, and leadership. She is a residency-trained graduate of the University of the Sciences’ Philadelphia College of Pharmacy and a Fellow of the American Society of Health-System Pharmacists. |
Activity Number
0033-9999-19-074-L05-P
Date:
09/20/19
Time:
08:45 AM - 09:45 AM
CE Hours
1.00
Location
ARB Auditorium
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
This continuing education program, "Medication Safety Strategic Planning" is imperative for the target population of medication safety leaders in the healthcare field, nurses, pharmacists, and pharmacy technicians. Development of a medication safety strategic plan is critical for purpose-driven, key goals to improve medication safety and improve patient outcomes. This 60 minute continuing education program is catered to addressing the design of a strategic medication safety plan. Identification and classification of goals as well as setting time lines for goals will be addressed. This is a known area of knowledge deficit and when addressed and practiced will lead to a more successful medication safety program. The overall goal is to teach the audience how to develop a long-term plan for medication safety improvements with achievable short term goals.
Objectives
- Identify key elements of a medication safety strategic plan.
- Identify appropriate strategic goals for medication safety strategic plans.
- Identify the tools needed for developing a medication safety strategic plan.
Speaker(s)/Author(s)
|
Melissa M. Diamond, BA, MS, PharmD, CRPh
|
Activity Number
0033-9999-19-063-L05-P
Date:
09/20/19
Time:
10:00 AM - 11:00 AM
CE Hours
1.00
Location
ARB Auditorium
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
The practice of measuring and recording an accurate body weight for all patients at the time of a hospital admission is essential for the delivery of safe patient care and considered a standard practice for all hospital admissions. This quality improvement initiative at a single community care hospital aimed at enhancing a culture of safety and value to achieve a standard practice of measured and accurate recorded daily body weight on all patients.
Objectives
- List the benefits of confirming an accurate, measured patient body weight on all newly admitted patients.
- Explain the required elements for describing a culture of awareness that supports the purpose of a safety goal with respect to accurate patient weight reporting.
Speaker(s)/Author(s)
|
Bonnie B. Jump, RDN, CSG, LD
|
|
|
Donna Poole, BSN, RN
|
|
|
Jessica Stauffer-Engelbrecht, MS, RDN, LD, CNSC
|
|
|
Kalli Castille, MS, RD, LD, FAND
|
Activity Number
0033-9999-19-070-L05-P
Date:
09/20/19
Time:
11:10 AM - 11:40 AM
CE Hours
0.50
Location
ARB Auditorium
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
To educate health care professionals on the challenges associated with medication reconciliation and how to decrease medication errors at all transitions of care. Major topics will include the data collection we are currently performing looking at the most common types of errors made during the process, and a description of our attempt at a standardized med rec work flow at St Louis Children’s Hospital. I will discuss multiple barriers, but will highlight importance of proper education, communication, and coordination between professions, especially roles and responsibilities of all interdisciplinary teams involved. Since pharmacist-led medication reconciliation processes have been shown to reduce medication errors, I will also discuss ways St Louis Children's pharmacy team is getting more involved and positively impacting our patients.
Objectives
- Identify potential barriers to performing accurate, reliable medication reconciliations.
- List some of the most common mistakes made during medication reconciliation.
Speaker(s)/Author(s)
|
Madeline Normansell, Pharm.D.
|
Activity Number
0033-9999-19-077-L05-P
Date:
09/20/19
Time:
11:10 AM - 11:40 AM
CE Hours
0.50
Location
ARB 222
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
Automated Dispensing Cabinets (ADC) provide many benefits to the modern drug dispensing model within a hospital, including unique features that can improve medication safety when used appropriately. ADC medication overrides, while necessary in certain situations, provide a work around for these cabinet safety features. Effective 2018, a new Joint Commission Medication Management standard outlined requirements for institutions to implement a policy regarding medication overrides for automated dispensing cabinets, including reviews of appropriateness of overrides. At our facility, review of medication overrides has identified unforeseen challenges caused by human factors and unique system barriers to full utilization of ADCs potential.
Objectives
- Identify practices related to safe and appropriate ADC use, including those related to medication overrides, based on accreditation standards and safety guidelines.
- Recognize unique systems issues and human factors that complicate efforts to improve appropriateness of medication overrides.
Speaker(s)/Author(s)
|
Ethan Wahl, Pharm.D.
|
Activity Number
0033-9999-19-065-L05-P
Date:
09/20/19
Time:
11:50 AM - 12:20 PM
CE Hours
0.50
Location
ARB Auditorium
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
Medication take-back programs provide a safe and environmentally friendly method of removing unused and expired prescription medications from the home. With the ongoing opioid epidemic at the forefront of government public health efforts today, medication take-back programs provide a method to decrease the amount of controlled substances available in the home for misuse and abuse. Hospitals with an on-site pharmacy are at a unique vantage point to provide patients with an option for safe disposal. Edward-Elmhurst Health implemented a medication take-back program using on-site collection boxes in January 2019. The path to the medication take-back program's implementation, beginning with identifying key stake-holders needed for collaboration, will be presented. Early collection data and day-to-day maintenance operation details are reviewed. The goal for audience members is to improve knowledge surrounding the provision of medication-take back programs in your own institution after the completion of this education.
Objectives
- Identify the steps of the process of implementing a medication take-back program.
- Identify key stakeholders for collaboration in order to create and implement a successful medication take-back program.
Speaker(s)/Author(s)
|
Kathryn Wdowiarz, Pharm.D., BCPS
|
|
|
Tina Bobo, RN, MSN
|
Activity Number
0033-9999-19-075-L05-P
Date:
09/20/19
Time:
11:50 AM - 12:20 PM
CE Hours
0.50
Location
ARB 222
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
Opioid Stewardship has become a larger topic within the last few years. As part, how to have process improvement within a section has not been widely hardwired mainly due to expectations that human vigilance is enough and fear of workarounds. This presentation looks at general concepts when attempting to hardwire to avoid these pitfalls.
Objectives
- Identify the most effective error prevention strategy.
- Predict when a ??work-around????should be proactively identified and guarded against prior to implementation of interventions
Speaker(s)/Author(s)
|
Joel Daniel, Pharm.D., MS, CPPS
|
Activity Number
0033-9999-19-071-L05-P
Date:
09/20/19
Time:
01:30 PM - 02:00 PM
CE Hours
0.50
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
Despite a focus on patient safety, medical errors are inevitable. When a medication error occurs, patients and their families want to know the details of what happened. However, a gap exists between the occurrence and its disclosure to the patient and/or their family. The response of healthcare professionals involved requires a debated, yet important, decision of whether to disclose the error to the patient and how much detail to include. The objective of this presentation is to increase awareness (and hopefully elicit behavior change) as it relates to the proper disclosure of a medication error. A brief review of recent medical literature and description of results of a nationwide study will be included to further highlight the need to educate pharmacy professionals on how to disclose an error to patients. Using this information, an initial framework for dealing with the disclosure of medication errors will be proposed. Audience participation will be encouraged via discussion and audience response poll questions.
Objectives
- Identify what patients want to hear when a medical error occurs.
- Identify components of a medication error disclosure framework.
Speaker(s)/Author(s)
|
Jennifer Mazan, Pharm.D.
|
Activity Number
0033-9999-19-067-L05-P
Date:
09/20/19
Time:
02:00 PM - 02:30 PM
CE Hours
0.50
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This session is is approved as a knowledge-based CPE activity. Due to unforeseen circumstances, this activity will now be delivered as a home study activity. To complete requirements for this activity, please view the video below and then complete a post-test. You must pass the post test with a minimum correct score of 70%. You may take the test as many times as you need. After the post-test, please complete the evaluation as with all other programs. The evaluation code can be found in the program booklet. The evaluation for this program expires at the same time as all other evaluations in this conference. If you would like, you may watch the recording during the conference during the previously scheduled time it was intended to be delivered live: Friday, September 20th 2:30 to 3:15 pm in ARB 212.
The goal of this CPE activity is to provide learners with an understanding of how incorporating a "human factors approach" to event investigation can facilitate learning from errors and support the culture of safety within a department or organization as a whole. The scope of the activity will focus primarily on how individual tasks (clinical and nonclinical) interact with organizational infrastructure and culture to determine safety. The perspective taken will be from that of a medication safety professional or pharmacy leader who investigates medication adverse events.
Objectives
- Identify how hindsight bias limits the ability to learn from system failures.
- Identify the steps to investigate safety events to reveal goal conflicts.
- Identify types of goal conflicts that can lead to unsafe practices in healthcare.
Speaker(s)/Author(s)
|
Charlene Hope, Pharm.D., MS, BCPS, CPPS
|
Activity Number
0033-9999-19-072-H05-P
Release Date:
Sep 20, 2019
Credit Expiration Date:
Sep 20, 2022
CE Hours
0.75
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This session is accredited as an application-based CPE activity.
Effective team work is vital to the development of an environment for safe medication use. The utilization of an Escape Room creates a life-life environment that rewards players for working together, discovering clues, solving puzzles, and completing successions of mind-bending tasks in order to ‘escape the room’ in the time allotted. Published literature has demonstrated how the use of Escape Rooms have increased students’ knowledge after completion of the game.
This 90 minutes presentation will describe what an Escape Room is, how medication safety can be incorporated into a game, and ultimately utilized to improve medication safety. Participants will then participate in an interactive ‘Escape Room.’
Objectives
- Define the ways an Escape Room can be utilized to teach and encourage a medication safety culture.
- Given an Escape Room scenario, identify the medication error.
- Identify opportunities within one's home practice to incorporate an Escape Room to address medication safety concerns.
Speaker(s)/Author(s)
|
Amanda Place, Pharm.D., BCACP
|
|
|
Heather A. Dossett, Pharm.D., MHA, BCPS, CPHQ
|
Activity Number
0033-9999-19-078-L05-P
Date:
09/20/19
Time:
03:30 PM - 05:00 PM
CE Hours
1.50
Location
ARB 222
Registration Closed
Registration closes on Sep 20, 2019
at 12:00 AM
Registration closes on Sep 20, 2019
at 12:00 AM
Registration Closed
Registration Closed
This session is accredited as an application-based CPE activity.
The overall goal of this presentation is to provide improved pain management processes that are safe and effective to apply to the inpatient pain management process. This includes general principles, a multi-modal pain management order set that maximizes non-opioid foundation, and process for identifying and measuring patient's activity goals.
Objectives
- Recall at least three practices that aid in improved pain management.
- Compare the different treatment modalities between the current and new pain management processes.
- Explain how to use the therapeutic activity goal to assess the need for opioid administration.
Speaker(s)/Author(s)
|
Judy Henderson, RN MSAH-M
|
|
|
Karen R. Smethers, BS, Pharm.D., BCOP
|
Activity Number
0033-9999-19-068-L01-P
Date:
09/21/19
Time:
09:00 AM - 10:00 AM
CE Hours
1.00
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
A brief overview of the existing literature on medication hoarding will bring participants up-to-date on the topic and its relevance during the opioid epidemic. Presenters will share the Medication Saving Behaviors scale (self-report and family member versions), a new measure with reliability and validity data. This tool can help healthcare practitioners identify high risk patients and target interventions to prevent medication mismanagement. In addition, appropriate communication to patients and caregivers on drug storage and disposal may reduce medication-related risks.
During the first half of this presentation participants will learn about the risks of excessive Medication Saving Behaviors and be able to identify potential problems. For instance, our research has identified that patients who have more Medication Saving Behaviors also have more adherence problems. During the opioid epidemic, excessive Medication Saving Behaviors provide a supply of medications that may potentially be misused, diverted, or used in a suicide attempt. When there are children in the home, access to unlocked medications may result in pediatric poisonings. Therefore, proper use, locked storage, and prompt disposal of risky medications promote medication safety.
The second half of the presentation will involve specific examples for small group discussion on best practices for managing medications in the home. Each participant will rate medication scenarios for usage, storage, and disposal. Pharmacy students will help facilitate this small group activity, including a discussion of access to necessary medications and other considerations for our families, our patients, and our community.
Objectives
- List 3 Medication Saving Behaviors-related problems.
- Classify proper usage, storage, and disposal of sample drugs.
Speaker(s)/Author(s)
|
Melanie VanDyke, PhD
|
Activity Number
0033-9999-19-066-L05-P
Date:
09/21/19
Time:
10:00 AM - 10:30 AM
CE Hours
0.50
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This session is accredited as a knowledge-based CPE activity.
Many States are legalizing Medical Marijuana and Cannabidiol can now be purchased legally in all 50 states. As pharmacists encounter more and more patients on these products they must understand their risks/benefits. What are the Drug-Drug Interactions and Side Effects of these products. This CE program will provide pharmacists with the knowledge they need to care for patients taking these products.
This activity will introduce the possible uses, contraindications, drug interactions, and side effects of medical marijuana and cannabidiol. Pharmacists will gain knowledge they need to council patients that are taking or considering taking these products.
Objectives
- Compare and contrast the pharmacology, adverse reactions, and interactions of THC and CBD.
- Identify the risks and benefits of cannabidiol (CBD) products.
Speaker(s)/Author(s)
|
Gregory P. Burger, Pharm.D., CPPS, NREMT, FASHP
|
Activity Number
0033-9999-19-069-L01-P
Date:
09/21/19
Time:
10:30 AM - 11:00 AM
CE Hours
0.50
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This session has been accredited as a knowledge-based CPE activity.
The overall structure of the continuing education program "System Design and Risk Reduction Strategies for High Alert Medications" will be an interactive, didactic lecture. The program will be considered successful when the audience walks away being able to articulate the following key concepts (1) Identify three primary goals of good system design relative to safe medication use (2) Differentiate between high leverage and low leverage error reduction strategies.
Objectives
- Identify three primary goals of good system design relative to safe medication use.
- Differentiate between high leverage and low leverage error reduction strategies.
Speaker(s)/Author(s)
|
Melissa M. Diamond, BA, MS, PharmD, CRPh
|
Activity Number
0033-9999-19-064-L05-P
Date:
09/21/19
Time:
11:00 AM - 11:30 AM
CE Hours
0.50
Location
ARB 212
Registration Closed
Registration Closed
Registration Closed
This activity is accredited as a knowledge-based CPE activity.
This activity contains seven pearls as follows:
(1) Table Top Simulations: Recommendations for Quick Value-Added Activities for New MSOs - Joel Daniel, Pharm.D., MS, CPPS
Learning Objective: Identify when a tabletop simulation is appropriate as a CQI tool.
Learning Objective: Identify when a tabletop simulation is appropriate as a CQI tool.
(2) Improving Medication Safety from the Source: Leveraging Vendor Partnerships to Improve Patient Care - Jessalynn Henney, Pharm.D.
Learning Objective: Describe the various benefits which may be seen when collaborating with vendors during new product development
Learning Objective: Describe the various benefits which may be seen when collaborating with vendors during new product development
(3) Preventing Sterile Compounding Errors in a Pediatric Satellite Pharmacy by using an Automated Software Program - Kelsey Habighorst, Pharmacy Student and Mallory Linck, Pharm.D.
Learning Objective: Explain the benefit of guided reminders when sterile compounding for the pediatric population.
(4) The safe and practical use of U500 regular insulin – Lauren Odum, Pharm.D., BCPS and Melissa Mays, Pharm.D.
Learning Objective: Recognize patients who have an indication for U500 regular insulin.
Learning Objective: Recognize patients who have an indication for U500 regular insulin.
(5) Improving safety of antibiotic locks through policy change at a pediatric institution – Alexander Milligan, Pharm.D. and Damon Pabst, RPh
Learning Objective: Identify potential adverse drug reactions that may occur with antibiotic-lock therapy use secondary to system and knowledge gaps.
(6) Collaborating to standardize concentrations of oral compounded medications - Nathan Walleser, Pharm.D., BCPS
Learning Objective: Explain potential benefits of standardizing concentrations of oral compounded medications.
(7) Identifying and Monitoring Patients at Highest Risk for OIRD - Paul Milligan, Pharm.D.
Learning Objective: Describe the current state of Opioid-Induced Respiratory Depression (OIRD) assessment algorithms, and their strengths and weaknesses.
Learning Objective: Describe the current state of Opioid-Induced Respiratory Depression (OIRD) assessment algorithms, and their strengths and weaknesses.
Objectives
- Describe the current state of Opioid-Induced Respiratory Depression (OIRD) assessment algorithms, and their strengths and weaknesses.
- Describe the various benefits which may be seen when collaborating with vendors during new product development
- Identify when a tabletop simulation is appropriate as a CQI tool.
- Recognize patients who have an indication for U500 regular insulin.
- Identify potential adverse drug reactions that may occur with antibiotic-lock therapy use secondary to system and knowledge gaps.
- Explain the benefit of guided reminders when sterile compounding for the pediatric population.
- Explain potential benefits of standardizing concentrations of oral compounded medications.
Speaker(s)/Author(s)
|
Alexander Milligan, Pharm.D.
|
|
|
Damon B. Pabst, RPh
|
|
|
Jessalynn Henney, Pharm.D.
|
|
|
Joel Daniel, Pharm.D., MS, CPPS
|
|
|
Kelsey Habighorst
|
|
|
Lauren Odum, Pharm.D., BCPS
|
|
|
Mallory Linck, Pharm.D.
|
|
|
Melissa Mays, Pharm.D.
|
|
|
Nathan Walleser, Pharm.D., BCPS
|
|
|
Paul Milligan, Pharm.D.
|
Activity Number
0033-9999-19-076-L05-P
Date:
09/21/19
Time:
12:45 PM - 02:00 PM
CE Hours
1.25
Location
ARB 212
Registration Closed
